TOP STORIES

• BUSINESS Oncolys Aims to Bring Nucleocapsid Inhibitor into Clinic Next Year for COVID-19 Treatment
  October 6, 2021

• REGULATORY Transparency and Predictability Up for Discussion towards 2022 Drug Pricing Reform: New Minister
  October 6, 2021

• REGULATORY New Health Minister Goto Vows to Protect Secure Healthcare System in FY2022 Reform
  October 5, 2021

• REGULATORY No Factor to Impede Reinstatement of HPV Vaccine Recommendation: Panels
  October 4, 2021

• ORGANIZATION FPMAJ to Define Shipment Situation in Preparation for Supply Information Centralization
  October 1, 2021

• BUSINESS Sumitomo Dainippon, Otsuka Ink Global Collaboration for 4 Neuropsychiatric Drugs
  October 1, 2021

• REGULATORY Pharma Officials Air Hopes and Concerns for New LDP Leader, Eyes on MHLW Revamp
  September 30, 2021

• ORGANIZATION FPMAJ Chief Praises Political Acumen of New LDP Leader Kishida, Seeks Support for Industry
  September 30, 2021

• COMMENTARY 5 Companies Developing Japan-Made COVID-19 Jabs Face Challenges in Subject Enrollment, Trial Designs
  September 29, 2021

• BUSINESS Shionogi Kicks Off Japan PII/III Trial for Oral COVID-19 Drug
  September 29, 2021

• REGULATORY Japan Approves Padcev, Entresto’s Hypertension Use, Lilly’s RET Inhibitor and More
  September 28, 2021

• REGULATORY Japan Approves GSK’s COVID-19 Antibody Drug, 2nd Treatment for Mild Cases
  September 28, 2021

• ORGANIZATION Chuikyo Payer Rep Wants to Cut into Cost-Based Method, Adjustment Rate, Off-Year Revision in FY2022 Reform, Eyes Special Rules for Aducanumab
  September 27, 2021

• BUSINESS Startup Headed by Ex-Biogen Japan Chief Working to Develop New Alzheimer’s Drugs Using Photocatalysts
  September 27, 2021

• REGULATORY One-Month Business Suspension Order Likely for Choseido over Generic Recalls
  September 24, 2021

• BUSINESS Shionogi to Begin PII/III Study for Oral COVID-19 Drug on Sept. 27: President
  September 24, 2021

• BUSINESS Shionogi Gets New Oral COVID-19 Drug into Clinic in Less than 1 Year, Now Gearing Up for PII/III
  September 24, 2021

• ORGANIZATION JPMA Chief Opposes Macroeconomic Indexing, Says Drugs Should Drive Economic Growth
  September 22, 2021

• REGULATORY GSK/Vir’s COVID-19 Drug Up for MHLW Panel Review on Sept. 27
  September 22, 2021

• BUSINESS New Heart Failure Drugs Jostling with Different Modes of Action, Offering Variety of Options
  September 21, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• …
• Next ›
• 最終 »